Management of pellucid marginal corneal degeneration with simultaneous customized photorefractive keratectomy and collagen crosslinking.

Détails

ID Serval
serval:BIB_CD5AC48FF194
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Management of pellucid marginal corneal degeneration with simultaneous customized photorefractive keratectomy and collagen crosslinking.
Périodique
Journal of cataract and refractive surgery
Auteur(s)
Kymionis G.D., Karavitaki A.E., Kounis G.A., Portaliou D.M., Yoo S.H., Pallikaris I.G.
ISSN
1873-4502 (Electronic)
ISSN-L
0886-3350
Statut éditorial
Publié
Date de publication
07/2009
Peer-reviewed
Oui
Volume
35
Numéro
7
Pages
1298-1301
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
A 34-year-old woman had simultaneous photorefractive keratectomy and corneal collagen crosslinking with riboflavin-ultraviolet-A irradiation for the treatment of progressive pellucid marginal corneal degeneration in both eyes. No intraoperative or early postoperative complications occurred. Twelve months postoperatively, the uncorrected visual acuity was assessed at 20/40 in both eyes compared with counting fingers preoperatively. The corrected visual acuity also improved from 20/50 and 20/63 to 20/25 and 20/32 in the right eye and left eye, respectively. Corneal topography revealed a significant improvement in both eyes. Despite the encouraging results, longer follow-up is necessary to confirm the stability of the results.
Mots-clé
Adult, Collagen/metabolism, Cornea/metabolism, Cornea/physiopathology, Corneal Dystrophies, Hereditary/physiopathology, Corneal Dystrophies, Hereditary/surgery, Corneal Topography, Female, Humans, Intraoperative Complications, Lasers, Solid-State/therapeutic use, Photochemotherapy/methods, Photorefractive Keratectomy/methods, Photosensitizing Agents/therapeutic use, Postoperative Complications, Riboflavin/therapeutic use, Ultraviolet Rays, Visual Acuity/physiology
Pubmed
Web of science
Création de la notice
01/10/2019 17:02
Dernière modification de la notice
06/10/2019 6:26
Données d'usage